17. November 2009 04:58
New antibiotics for methicillin-resistant Staphylococcus aureus (MRSA) and other pesky bacteria. Andrei Osterman and collaborators have used comparisons of bacterial genomes to identify new targets for antibiotics and produced first-generation chemical inhibitors of a class of bacterial enzymes, called NadDs (nicotinate mononucleotide adenylyltransferases).
[More]
a7bd67ba-2c84-4ccf-8674-066aea4a1ec5|0|.0
Posted in: Device / Technology News | Medical Science News
Tags: Antibiotic, Anti-Inflammatory, Blood Vessel, Brain, Cancer, Cell, Diabetes, Hydrogen Peroxide, Immunosuppression, Insulin, Insulin Resistance, Juvenile Diabetes, Metastasis, Neurological Disease, Obesity, Parkinson's Disease, Pathology, Staphylococcus aureus, Stem Cell
2. November 2009 03:47
Extending hepatitis C treatment for liver transplant patients beyond current practice results in high rates of clearance of the hepatitis C virus from the blood, as well as a low rate of relapse, according to a Henry Ford Hospital study.
[More]
31. October 2009 03:27
The race of kidney donors may affect the survival rates of transplant recipients according to a study by Henry Ford Hospital.
[More]
30. October 2009 06:54
Isotechnika Pharma Inc. today announced that it has developed a portfolio of non-immunosuppressive cyclosporine analogue molecules (NICAMs) with potent cyclophilin inhibition. Cyclophilin inhibition has garnered considerable attention as a novel therapy in the treatment of a wide range of diseases including hepatitis C, stroke, and chronic neurological disorders such as Parkinson's, Lou Gehrig's, and Alzheimer's.
[More]
27. October 2009 02:59
Findings from a new retrospective cohort study presented at the American College of Gastroenterology's 74th Annual Scientific meeting in San Diego indicate that patients with Inflammatory Bowel Disease (IBD), especially those receiving the thiopurine class of medications to treat IBD, may be at risk for developing non-melanoma skin cancer (NMSC).
[More]
a494a199-5ea1-4c4e-9534-5042512a5b48|0|.0
Posted in: Medical Condition News
Tags: Azathioprine, Cancer, Crohn's Disease, Gastroenterology, Immunosuppression, Inflammatory Bowel Disease, Irritable Bowel Syndrome, Melanoma, Skin Cancer, Stress, Transplant, Ulcerative Colitis
23. October 2009 05:06
Each year 3-5 million people have severe cases and 250-500,000 die from complications of seasonal influenza world-wide. This year, the novel 2009 H1N1 (nH1N1) influenza, previously called swine flu, has reached pandemic status.
[More]
23. October 2009 04:57
Each year 3-5 million people have severe cases and 250-500,000 die from complications of seasonal influenza world-wide. This year, the novel 2009 H1N1 (nH1N1) influenza, previously called swine flu, has reached pandemic status.
[More]
22. October 2009 03:31
Peregrine Pharmaceuticals, Inc. today reported positive results from its Phase II trial evaluating bavituximab in combination with docetaxel in patients with advanced breast cancer.
[More]
20. October 2009 05:40
Novartis announced today that Tasigna (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the company's groundbreaking drug Gleevec (imatinib mesylate) tablets*. Tasigna produced faster and deeper responses than Gleevec when given as first-line therapy for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna was well tolerated in the study.
[More]
003e4c23-c045-4e9b-9be9-62e458918f8f|0|.0
Posted in: Drug Trial News | Medical Condition News
Tags: Acetaminophen, Anemia, Biomarker, Bone, Bone Marrow, Cancer, Cell, Chemotherapy, Chromosome, Chronic Myeloid Leukemia, Congestive Heart Failure, Constipation, Contraception, Diarrhea, Edema, Erythromycin, Gleevec, Haloperidol, Headache, Heart Failure, Hematology, Hyperglycemia, Hyponatremia, Hypothyroidism, Imatinib Mesylate, Immunosuppression, Leukaemia, Leukemia, Leukopenia, Metabolism, Methadone, Myeloid Leukemia, Nausea, Neutropenia, Nursing, Oncology, Pancreatitis, Pathology, Pneumonia, Pregnancy, Thrombocytopenia, Vomiting, Warfarin
15. October 2009 00:34
A newer, less expensive drug used to suppress the immune system and prevent organ rejection in kidney and pancreas transplant patients works just as well as its much more expensive counterpart, according to a new study by researchers at Wake Forest University Baptist Medical Center.
[More]
30. September 2009 03:06
LifeCycle Pharma A/S today announced positive results from a completed 12 month extension phase of the Phase 2 clinical study of LCP-Tacro tablets in stable liver transplant patients.
[More]
21. September 2009 10:02
Enzo Biochem, Inc. (NYSE: ENZ), announced today that it had entered into a Cooperative Research and Development Agreement (CRADA) with the National Eye Institute, part of the National Institute of Health, to conduct a human clinical trial of Optiquel™, Enzo’s oral, proprietary therapeutic for chronic autoimmune uveitis.
[More]
3f37e6fd-6936-46ab-8124-157177f98eac|0|.0
Posted in: Drug Trial News | Medical Condition News
Tags: Blindness, Bone, Cataract, Crohn's Disease, Glaucoma, Health and Human Services, Immunology, Immunosuppression, Osteoporosis, Pathology, Uveitis
18. September 2009 02:35
The SCCA House, an 80-unit patient housing facility for cancer patients and their families and caregivers, was dedicated today during ceremonies at its South Lake Union location. The facility is the second such "home away from home" building that is operated by the Seattle Cancer Care Alliance. Rooms are scheduled to be available to SCCA patients by the end of the month.
[More]
16. September 2009 05:27
A Toll-like receptor (TLR) agonist, called imiquimod, which activates dendritic cells, is in clinical use as a topical application for basal cell carcinoma. In addition, a number of TLR agonists have been evaluated in clinical trials as an adjuvant for cancer vaccines.
[More]
15. September 2009 06:22
The American Society of Transplantation (AST) presents Transplantation: The Year in Review, Oct. 24-25, 2009 in Houston, Texas. The meeting features a review of the most recent developments in the field of organ transplantation from May 2008 up to and including the 2009 American Transplant Congress (ATC) that was held in May in Boston.
[More] 
Subscribe